Flinton Capital Management’s Medicines Co MDCO Stock Holding History

Flinton Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$870K	Buy	17,408 +816	+5%	+$32.6K	0.03%	335
2019 Q2	$605K	Buy	16,592 +476	+3%	+$15.5K	0.02%	426
2019 Q1	$451K	Hold	16,116	–	–	0.01%	482
2018 Q4	$308K	Buy	16,116 +3,638	+29%	+$84.6K	0.01%	550
2018 Q3	$373K	Buy	12,478 +2,516	+25%	+$94.8K	0.01%	567
2018 Q2	$365K	Buy	9,962 +442	+5%	+$14.4K	0.01%	515
2018 Q1	$314K	Hold	9,520	–	–	0.01%	537
2017 Q4	$260K	Buy	9,520 +1,360	+17%	+$41.9K	0.01%	596
2017 Q3	$302K	Buy	8,160 +1,122	+16%	+$41.4K	0.01%	511
2017 Q2	$267K	Buy	7,038 +3,026	+75%	+$135K	0.01%	512
2017 Q1	$196K	Buy	4,012 +442	+12%	+$20.2K	0.01%	503
2016 Q4	$121K	Buy	+3,570	New	+$127K	0.01%	563

Other funds holding MDCO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Flinton Capital Management's MDCO Position: Q3 2019 in Review

Flinton Capital Management increased its Medicines Co (MDCO) stake by 4.9% in Q3 2019, buying an estimated $32.6K and bringing the position to 17,408 shares worth $870K. The position accounts for 0.03% of the portfolio, ranked #335.

Flinton Capital Management first reported a position in MDCO in Q4 2016 and has held it in 12 quarters since. 250 funds tracked by Wall St. Rank hold MDCO as of Q3 2019.

Flinton Capital Management held 17,408 shares of Medicines Co worth $870K as of Q3 2019.
Flinton Capital Management bought 816 Medicines Co shares in Q3 2019, an estimated $32.6K.
Medicines Co made up 0.03% of Flinton Capital Management's portfolio in Q3 2019, its #335 holding.
Flinton Capital Management first reported a position in Medicines Co in Q4 2016 and has held it in 12 quarters since.
250 funds tracked by Wall St. Rank held Medicines Co as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.